Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With Fusion-Positive Breast Cancer.
作者信息
Watanabe Satomi, Takeda Masayuki, Otani Tomoyuki, Yoshida Takeshi, Sakai Kazuko, Olek Elizabeth, Rothenberg S Michael, Kherani Jennifer, French Pearl P, Nishio Kazuto, Ito Akihiko, Nakagawa Kazuhiko
机构信息
Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Department of Pathology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
出版信息
JCO Precis Oncol. 2021 Jan 11;5. doi: 10.1200/PO.20.00282. eCollection 2021.
Abstract
摘要
Zotero 插件